MedTrace Logo

Active Surveillance for Cancer of the Prostate (ASCaP)

NCT00949819 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 462

Last updated 2025-05-13

No results posted yet for this study

Summary

Active Surveillance (A.S.) of prostate cancer (CaP) is the systematic monitoring of men with low-risk, localized lesions, with curative treatment of those whose tumors show substantial progression. A.S. is different from Watchful Waiting (W.W.), which is the palliative treatment of men with progressive prostate cancer.

Conditions

Interventions

OTHER

Active surveillance

Serial, long term data collection and active surveillance

Sponsors & Collaborators

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Leonard S Marks, M.D. · University of California, Los Angeles

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-04
Primary Completion
2027-07-05
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00949819 on ClinicalTrials.gov